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Background: This cross-sectional study examined the associations of hormones and age with 
short-term memory and perceptual capacity in 472 healthy Asian men. Methods: The symbol 
digit and digit span tests from the Swedish Performance Evaluation System were used to assess 
perceptual capacity and memory. Linear regression analyses with the stepwise method were 
carried out with the SPSS 21.0 package. Results: Age was associated with lower 
dehydorepiandrosterone sulphate (DHEAS), insulin growth factor-1 (IGF-1), thyroxine (T4), 
testosterone (T), bioavailable T (BioT), and error rate (Err) but higher glucose (GLU), sex 
hormone binding globulin (SHBG), estradiol (E2) and retention time (RT). High GLU was 
associated with higher error rate, longer RT of the perceptual capacity domain and shorter 
DSpan of the short memory domain. Higher BP3 was associated with longer DSpan.  High Cor 
was associated with higher Err, while high DHEAS was associated with shorter RT. All other 
hormones from the adrenal, somatotrophic and gonadal were not significantly associated with 
cognition. Conclusion: The findings suggest 1) a role for tighter control of blood glucose 
levels in cognitive decline with aging in both healthy and diabetic people, 2) different 
hormones may be related to different parameters of cognition and “cognition” is not a unitary 
phenomenon and 3) further investigation of the potential for exogenous DHEAS to slow 











Aging is associated with changes in the functionality of various health compartments, 
including that of metabolic, cardiovascular, cognitive and endocrine compartments [1-6]. In 
addition, the effects of aging occur in an inter-compartmental manner, where changes in one 
may affect others [7, 8]. Evidence is beginning to accumulate which suggests that age-related 
changes in endocrine activities may be related to cognitive decline in man [9]. However, a 
direct relationship between cognitive and endocrine changes has been difficult to prove. The 
difficulty may, in part, be due to the complexity of human cognition and the lack of accurate 
and reliable tools to measure the functional capacity of the different cognitive domains. 
Furthermore, it has been shown that cognition is affected by many factors including lifestyle, 
biochemical, social, environmental, genetic and hormonal factors [8, 10, 11]. Amidst the many 
confounding factors, the challenge to tease out the individual factors having independent 
association with cognition is considerable. It is unclear whether age-related changes in the 
various endocrine axes are associated with cognition.  
 
The gonadal, adrenal, somatotrophic and thyroid axes may have roles in the establishment and 
modulation of human behavior and cognition [9]. However, the associations of these endocrine 
axes with cognition and their potential effects on the aging brain remain uncertain [9]. 
Androgens were noted to be associated with visuospatial functions in elderly men on 
testosterone therapy and in men with Alzheimer’ disease (AD) or mild cognitive impairment 
(MCI) [12-15], but others have shown otherwise [16-18]. The conflicting results could be 
related to the ages of the men, the endogenous levels of testosterone present and the cognitive 
function tests employed.  
 
The adrenals secrete large amounts of DHEA and DHEAS (DHEA/S) and cortisol. With aging, 
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there is a progressive and continuous decline of DHEA/S levels [19]. On the other hand, 
cortisol levels show a slight parallel linear increase with aging or remain largely unchanged 
[19]. Several earlier studies did not show a link of DHEA/S with cognition [20, 21], but others 
did [22-25]. The available evidence does not currently support a clear role of DHEA/S in 
improving or maintaining memory and other cognitive domains in healthy older individuals, 
but it might be useful in older persons with MCI or in the context of a hormonal deficiency 
[26].  
 
High levels of cortisol are associated with poorer memory and it seems to be associated with 
hippocampal function [27, 28]. However, it has also been shown that the decline in cognition 
with aging was not paralleled by changes in cortisol levels [29]. 
 
Somatotrophic hormones such as growth hormone (GH) and insulin-like growth factor-1 (IGF-
1) may play an important role in brain function [30]. Growth hormone and IGF-1 decline with 
age and the declines are associated with poorer cognitive functions [31, 32]. The link between 
lower levels of IGF-1 and poorer cognitive function was derived from both cross-sectional and 
intervention studies with GHRH therapy [33-35]. Whether endogenous levels of somatotrophic 
hormones have any modulating effects on cognition remains unclear.  
 
Clear evidence does exist on the role of thyroid hormones in adult brain function [36, 37]. 
Evidence of the association of thyroid hormones with cognition was derived from studies of 







SUBJECTS, MATERIALS AND METHODS 
Subjects  
This study involved analyses of data collected from a group of 472 men. Details of recruitment 
of the subjects have been reported in several earlier publications [7, 8]. Subjects were healthy 
men, aged between 29y to 72y living in the community.  
Methodologies  
Each subject answered a self-administered and investigator-guided questionnaire. Questions asked 
included medical, dietary, social, sex, and family histories and other histories regarding consumption 
of hormones, supplements and medication, types of beverages, smoking and alcohol consumption.  
 
To improve our understanding of the associations between hormones, aging and cognition, we 
have concurrently measured hormone levels, lifestyle factors and cognitive function in healthy 
men. This has enabled the evaluation of the individual hormones’ association with cognition 
with adjustment for various confounding factors.  
 
Cognitive function tests 
 
The Swedish Performance Evaluation System (SPES) was developed over the last 40 years 
[40]. Two tests from the SPES, the Symbol Digit for perceptual capacity and Digit Span for 
short-term memory were used in the study. 
Symbol Digit – The Symbol Digit is a test of perceptual capacity which includes matching, 
memory and the speed of processing. In one row, a key to this coding task is given by the 
pairing of symbols with randomly arranged digits, 1 to 9. The task is to key in as fast as 
possible the digits corresponding to the symbols presented in random order in a second row. 
Each set consists of nine pairs of randomly arranged symbols and digits, and a total of 10 sets 
are presented. Performance is evaluated as the mean reaction time (msec) (RT) and the number 
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of errors (Err) for the last 54 pairs of the test. Symbol Digit tests the individual’s ability to 
interpret and correctly match what he sees as well as the speed of his perceptual processing. It 
also involves hand-eye coordination. The two components of this test are reaction time (RT) 
and the number of errors (Err) [40]. 
 
Digit Span – The Digit Span is a test of short-term memory capacity. In this test, a series of 
digits is presented on the screen. The digits are presented one at a time with a 1-second 
presentation time, and the task is to reproduce the series on the keyboard. Depending on the 
answer, the length of the following series is either increased or decreased. The test starts with a 
series of three digits and it is terminated after six incorrect answers. Performance is evaluated 
as the maximum string of numbers (DSpan) that the subject could remember successfully. A 
longer DSpan indicates a better short term visual memory [40]. 
 
The digit symbol and digit span are computer-based tests. All participants underwent a 
familiarization trial test before the actual scorings were recorded.    
Exercise scores (MET-min) 
 
Exercise may interact with both hormone levels and with cognition [6, 8]. The type, duration and 
frequency/week of exercise for each participant were collated from data from the self-administered 
and investigator-guided questionnaire. The intensity of the physical exercise was scored using the 
Metabolic Equivalent of Task (MET) for each exercise type. The scoring took into account the 
duration of each exercise episode and the frequency of the exercise per week to derive an exercise 
score. In accordance with the guidelines for Americans [41], the MET cut-off values were as 
follows: light intensity (<3 MET), moderate intensity (3–6 MET) and high intensity (>6 MET). The 
total exercise score per week was expressed as metabolic equivalent-min (MET-min). The manner of 




Measurements of hormones  
 
Measurements for T, E2, DHEAS, Cortisol and SHBG 
 
A 12 h fasting blood sample was collected from each participant and serum separated and 
stored at -80
o
C. Serum testosterone (T) and estradiol (E2) concentrations were measured using 
reagents and methods recommended by the World Health Organization Matched Reagent 
Program [43] with modification to the scintillation proximity methods established in-house 
[44]. Dehydroepiandrosterone sulphate (DHEAS) and sex hormone binding globulin (SHBG) 
and cortisol (Cor) were measured by established radioimmunoassay methods reported earlier 
[45]. The intra- and inter-assay coefficients of variation were less than 10% over the effective 
concentration ranges for T, DHEAS, and Cor and less than 15% for E2 and SHBG.  
 
Measurements for IGF-1, BP3, INS, TSH, T4, T3 and GLU 
 
Serum concentrations of insulin-like growth factor-1 (IGF-I) and insulin like growth factor binding 
protein-3 (BP3) were measured using immunoradiometric assay kits (Diagnostic Systems 
Laboratories, Inc., Webster, TX) as reported earlier [46, 47]. The CV for duplication was <10%. The 
ranges for inter-batch-assay CV were 3.6–4.5% for serum IGF-I and 6–9% for serum BP3. Serum 
concentrations of insulin (INS), thyroid stimulating hormone (TSH), T4 and triiodothyronine (T3) 
were measured in-house using the Axsym platform from Abbott. Glucose levels were measured 
using the hexokinase method on the in-house Axsym platform.  
 
Method of calculation of Bioavailable T (BioT) 
BioT was calculated using the computer formula of Vermeulen, which is available on the 
ISSAM website (www.issam.ch). Total T was computed as ng/dL, and SHBG as nmol/L. 




Statistical analyses were performed using SPSS for windows version 21.0 (Armonk, NY). 
Multilinear regression with the stepwise method was used for the various hormonal factors 






Table 1 shows the correlation between age and hormones from the gonadal, adrenal, 
somatotrophic (including GLU) and the thyroid axes as well as the three parameters of 
cognition studied. Independent of other hormones, age was associated with decline in DHEAS, 
IGF-1, T4, T, and BioT, but increase in GLU, SHBG, E2 and RT. As was reported earlier [43], 
in this sample, the older Singaporean men were exercising more intensely than younger men 
(Table 1). Other hormones did not show any age-related changes (Table 1).  
 
Table 2 shows the linear regression analyses, using the stepwise method, of hormones from the 
gonadal, adrenal and somatotrophic axes, age and exercise score with the three cognitive 
parameters of Err, RT and DSpan. Glucose is an important factor in the somatotrophic axis and 
was included in the analyses. The circulating level of glucose was significantly associated with 
all three parameters of the two cognitive domains studied. High GLU was associated with 
higher error rate, longer RT of the perceptual capacity domain and shorter DSpan of the short 
memory domain (Table 2). The IGF-binding protein-3 (BP3), the other component of the 
somatotrophic axis, was significantly associated with the memory domain; higher BP3 was 
associated with longer DSpan (Table 2). As was reported in an earlier study, age was positively 
associated and MET-min was negatively associated, with RT of the perceptual domain (Table 
2). Two hormones from the adrenal axis, Cor and DHEAS, were significantly associated with 
cognitive functions. High Cor was associated with higher error rate (Err), while high DHEA/S 
was associated with shorter RT (Table 2). All other hormones from the adrenal, somatotrophic 
and gonadal axes were not significantly associated with the three parameters of the two 






The role of the neuroendocrine system, and in particular, the role of hormones in cognition has 
been established mainly through models of endocrine dysfunction such as congenital adrenal 
hyperplasia, menopause syndrome, hypogonadism, diabetes and hormone replacement therapy 
[9].  It is however, unclear to what degree, if any, age-related changes in endogenous hormone 
levels are associated with decline in cognition in aging men. The present cross-sectional study 
evaluated whether age-related differences in endogenous hormone levels are associated with 
cognitive functioning in healthy community living men.   
 
Aging has varying effects on healthy individuals, with some people exhibiting extensive 
alteration in physiological functions including cognition but others little or none [49-52]. As 
we have reported earlier, age and a lifestyle habit of physical exercise were significantly 
associated with the perceptual capacity [6]. Hence, in the present study, all correlational 
analyses of hormone levels with cognitive functions were adjusted for age and exercise 
intensity. If this is not done, the relationships of individual endogenous hormone levels with 
cognition might be confounded.   
 
The regression analyses showed that endogenous levels of GLU were significantly associated 
with all three parameters of the perceptual and short-term memory cognitive domains. Higher 
circulating levels of glucose were associated with poorer perceptual capacity, with higher error 
rate and longer retention time. At the same time, higher levels of glucose were associated with 
poorer short term visual memory. In the present study, none of the participants was diabetic or 
on medication for diabetes and their glucose levels were not in the pathological range. 
Therefore, the negative correlation of the glucose levels with the three parameters of cognition 
suggests that circulating levels of glucose per se may have a modulating effect on short term 
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memory and perceptual capacity. This finding implies that tighter control of blood glucose 
levels in diabetics and healthy men may modulate a high GLU-associated decline in cognition 
and should be investigated in future studies. 
 
It has been suggested that prenatal exposure to androgens strongly influences the cognitive 
pattern in adulthood [53]. Androgens (either directly or through conversion to estrogens) may 
be associated with visuospatial cognitive ability. This may be observed in patients with 
androgen excess, as in cases of congenital adrenal hyperplasia [54], and androgen insensitivity 
[55]. However, the association of androgens with cognition in studies of cross-sex hormone 
therapy in transsexuals and hormone replacement in hypogonadal men were equivocal [56, 57].  
In addition, the relation between baseline endogenous circulating androgens and spatial ability 
remains unclear [9]. We have shown that circulating levels of testosterone, BioT, SHBG and 
estrogen were not significantly associated with any of the three parameters of cognition, in line 
with observations of several earlier studies [27, 58, 59] but in contrast to some other studies 
[60, 61]. The observation that the age-associated decline in androgens and increase in estradiol 
were not associated with cognition implies that circulating endogenous levels of sex hormones 
may not have a direct effect on cognition in men. The results imply that none of the gonadal 
factors has a modulating effect on cognition.  
 
Cortisol and DHEA/S have been shown to be associated with human cognition [22, 26, 28].  
Age was associated with a linear decrease in DHEA/S levels, but not with circulating levels of 
cortisol. We have shown that higher cortisol levels were associated with higher error rate, and 
higher levels of DHEAS were associated with lower RT in the perceptual capacity domain. The 
results suggest that these two hormones from the adrenal gland may have a role in the 
perceptual capacity domain of human cognition. We have shown that after adjusting for age, 
 
11 
exercise intensity and other hormone levels, DHEA/S in a group of normal men aged 29y to 
72y was independently and significantly associated with cognition. By contrast, the 
Massachusetts Male Aging Study did not show any significant association between 
endogenous levels of DHEA/S and working memory, speed/attention and spatial ability in 
older men [27]. It has been suggested that a decline in DHEA/Cortisol ratio may underlie some 
of the cognitive decline associated with aging as DHEAS can attenuate the deleterious effects 
of cortisol [62, 63]. However, this suggestion was not borne out in the present study. We did 
not show any significant association of DHEAS/Cor ratio with any of the three parameters of 
cognition evaluated.  
 
While cortisol shows a relative steady level of secretion throughout aging, DHEAS synthesis 
peaks in young adulthood and declines with age and by up to 80% in old age [8, 64].   It has 
been suggested that the effect of DHEAS is mediated indirectly through conversion to 
androgen or estradiol [65]. However, as shown in the present study, androgens and E2 in the 
same group of men were not significantly associated with the two cognitive domains. This 
observation may imply a direct role of DHEAS per se in modulating the perceptual capacity. A 
direct role of DHEAS in cognition is supported by our earlier observation that DHEAS affects 
sexual motivation in men, whereas androgens and estrogens do not [66].   
 
Age-related decline in cognition and Alzheimer’s disease have been associated with high 
cortisol levels in some studies [28, 67, 68], but not in others [29, 69]. The reasons may relate to 
artefacts due to the biological media in which cortisol was measure and to the measures of 
cognitive functions used [28, 29, 68-70]. In the present study, we noted a direct correlation of 
circulating cortisol levels with the error rate in the perceptual capacity in healthy men. This 
observation is in contrast to that of Gaysina et al [27], who did not show a significant 
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relationship of morning cortisol to midlife cognition.   
 
Somatotrophic hormones play an important role in brain function [31]. Age-related decline in 
growth hormone (GH) and IGF1 in men concurrent with decline in cognition have been well 
established [31, 32, 71]. However, whether endogenous levels of somatotrophic hormones have 
modulating roles on real time cognitive functions in healthy men is less clear. As with 
circulating insulin, IGF-1 and the IGF/BP3 ratio were not significantly association with any of 
the three parameters of cognition evaluated. However, endogenous circulating levels of BP3 
were positively associated with short-term memory. These observations were in contrast to 
those of some earlier studies [72]. The result implied that BP3 per se may have a direct role in 
modulating the short-term memory domain in human cognition.  
 
Clear evidence exists on the role of thyroid hormones in adult brain function [36, 37]. Studies 
of patients with hypothyroidism and hyperthyroidism have shown that thyroid hormones are 
associated with cognition [38, 39]. However, in the present study none of the thyroid hormones 
was significantly associated with perceptual and short-term memory cognitive domains. This 
suggests that endogenous levels of T4, T3 and TSH may not have a modulating role in the 
short-term memory and perceptual capacity domains of human cognition in healthy men.       
 
We have shown that circulating levels of GLU, DHEA/S, Cor, and BP3 were significantly 
associated with at least one of the parameters of the perceptual and short-term memory 
domains of human cognition.  
 
A limitation of this study is that it is a cross-sectional study; hence no causal effect is 
attributable to the observed associations. Only two cognitive domains, the perceptual and 
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memory domains were studied, hence cross comparisons with studies with other domains of 
cognitions could not be made. On the other hand, a positive contribution of the present study is 
the involvement of a relatively wide age range (29 years to 72 years) of Asian men who were 
healthy with no history of any major illnesses that might mar the actual association of 
endocrine factors and age with cognition. In addition, a range of lifestyle factors was able to be 
controlled for. 
 
The findings suggest three conclusions and/or hypotheses for further investigation: 
1. A role for tighter control of blood glucose levels in cognitive decline with aging in both 
healthy and diabetic people. 
2. Different hormones may be related to different parameters of cognition and “cognition” 
(thus cognitive decline) is not a unitary phenomenon. 
3. The potential for exogenous DHEA/S to slow cognitive decline in aging, especially as 















We would like to acknowledge the technical assistance from staff of the Endocrine Research 
and Service Laboratory of the Department of Obstetrics and Gynaecology, National University 
of Singapore, Singapore. This study was designed, conducted and data collected while Prof. 
Victor H. H. Goh was at the Department of Obstetrics and Gynaecology, National University 
of Singapore, Singapore. Prof. William Hart was intimately involved in the interpretation, 
drafting of the article and critical revision of the article for submission. 
DECLARATION OF INTEREST 
The authors report no declaration of interest. This study was supported, in part, by funds from 































1. Leifke E, Gorenoi V, Wichers C, Von Zur Muhlen A, Von Buren E, Brabant G. Age-
related changes of serum sex hormones, insulin-like growth fator-1 and sex-hormone 
binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin 
Endocrinol 2000; 53:689-695. 
2. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Baltimore Longitudinal 
Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in 
healthy men. J Clin Endocrinol Metab 2001; 86:724-731. 
3. Morley JE, Kaiser F, Raum WJ, Perry HM III, Flood JF, Jensen J, Silver AJ, Roberts E. 
Potentially predictive and manipulable blood serum correlates of aging in the health 
human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone 
sulphate, and the ratio of insulin-like growth factor I to growth hormone. Proc Natl Acad 
Sci 1997; 94:7537-7542. 
4. Hanninen T, Koivisto K, Reinikainen KJ, Helkala EL, Soininen H, Mykkanen L, Laakso 
M, Reikkinen PJ. Prevalence of ageing-associated cognitive decline in an elderly 
population. Age and Ageing 1996; 25:201-205. 
5. Busse A, Bischkopf J, Riedel-Hellar SG, Angermeyer MC. Mild cognitive impairment: 
prevalence and incidence according to different diagnostic criteria. Results of the Leipzig 
Longitudinal Study of the Aged (LEILA75+) British J of Psychiat 2003; 182:449-454. 
6. Goh VHH, Hart WG. The association of metabolic syndrome and aging with cognition in 
Asian men. The Aging Male 2014; 17(4):216-222. 
7. Goh VHH, Tong TYY, Mok HPP, Said B. Interactions among age, adiposity, bodyweight, 
lifestyle factors and sex steroid hormones in healthy Singaporean Chinese men. Asian J 
Androl 2007; 9:611-21.  
8. Goh Victor HH, Tong Terry YY. The moderating impact of lifestyle factors on sex 
steroids, sexual activities and aging in Asian men. Asian J Androl 2011; 13:596-604. 
9. Erlanger DM, Kutner KC, Jacobs AR. Hormone and cognition: current concepts and issues 
in neuropsychology. Review article. Neuropsychol Rev 1999; 9(4):175-207. 
10. Nyberg F, Hallberg M. Growth hormone and cognitive function. Nat Rev Endocrinol 
2013; 9:357-365.  
11. Lamberts SWJ. The endocrinology of aging and the brain. JAMA Neurol 2002; 
59(11):1709-1711. 
12. Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. 
Longitudinal assessment of serum free testosterone concentration predicts memory 
performance and cognitive status in elderly men. J Clin Endocrinol Metab 2002; 87:5001-
5007. 
13. Cherrier MM, Matsumoto AM, Amory JK, Asthana S, Bremner W, Peskind ER, Raskind 
MA, Craft S. Testosterone improves spatial memory in men with Alzheimer disease and 
mild cognitive impairment. Neurol 2005; 64:2063-2068. 
14. Tan RS, Pu SJ. A pilot study on the effects of testosterone in hypogonadal aging male 
patients with Alzheimer‘s disease. Aging Male 2003; 6:13-17. 
15. Yaffe K, Lui L-Y, Zmuda J, Cauley J. Sex hormones and cognitive function in older men. 
J  Am Geriat Soc 2002; 50:707-712. 
16. Fonda SJ, Bertrand R, O’Donnell A, Longcope C, McKinlay JB. Age, hormones and 
cognitive functioning among middle-aged and elderly men: cross-sectional evidence from 
the Massachusetts Male Aging Study. J Gerontol Series A, Bio Sci Med Sci 2005; 60:385-
390. 
17. Sih R, Morley JE, Kaiser FE, Perry HM III, Patrick P, Ross C. Testosterone replacement 
in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol 
 
16 
Metab 1997; 82(6):1661-1667. 
18. Lu PH, Masterman DA, Mulnard R, Cotman C, Miller B, Yaffe K, Reback E, Porter V, 
Swerdloff R, Cummings JL. Effects of testosterone on cognition and mood in male 
patients with mild Alzheimer disease and healthy elderly men. Arch Neurol 2006; 63:177-
185. 
19. Yen SS. Dehydroepiandrosterone sulfate and longevity: new clues for an old friend. Proc 
Natl Acad Sci USA 2001; 98:8167-8169. 
20. Wolf OT, Koster B, Bierings HG, Kirschbaum C, Pietrowsky R, Kern W, Hellhammer 
DH, Born J, Fehm HL. A single administration of dehydroepiandrosterone does not 
enhance memory performance in young healthy adults, but immediately reduces cortisol 
levels. Biol Psychiatry 1997; 42:845-848. 
21. Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendorfer RA, 
Pirke KM, Kirschbaum C. Effects of a two-week physiological dehydroepiandrosterone 
substitution on cognitive performance and well-being in healthy elderly women and men. J 
Clin Endocrinol Metab 1997; 82:2363-2367. 
22. Hildreth KL, Gozansky WS, Jankowski CM, Grigsby J, Wolfe P, Kohrt WM. Association 
of serum dehydroepiandrosterone sulphate and cognition in older adults: sex steroid, 
inflammatory, and metabolic mechanisms. Neuropsychol 2013; 27:356-363. 
23. Valenti G, Ferrucci L, Lauretani F, Ceresini G, Bandinelli S, Luci M, Ceda G, Maggio M, 
Schwartz RS. Dehydroepiandrosterone sulphate and cognitive function in the elderly: the 
In CHIANTI study. J Endocrinol Invest 2009; 32:766-772. 
24. Haren MT, Banks WA, Perry III HM, Patrick P, Malmstrom TK, Miller DK, Morley JE. 
Predictors of serum testosterone and DHEAS in African-American men. Intl J Androl 
2008; 31:50-59. 
25. Sanders JL, Cappola AR, Arnold AM, Boudreau RM, Chaves PH, Robbins J, Cushman M, 
Newman AB. Concurrent change in dehydroepiandrosterone sulphate and functional 
performance in the oldest old: results from the Cardiovascular Health Study All Stars 
study. J Genrotol A Bio Sci Med Sci 2010; 65:976-981. 
26. Maggio M, De Vita F, Fisichella A, Colizzi E, Provenzano S, Lauretani F, Luci M, 
Ceresini G, Dall’Aglio E, Caffarra P, Valenti G, Ceda GP. DHEA and cognitive function 
in the elderly. J Steroid Biochem Mol Biol 2015; 145:281-292. 
27. Gaysina D, Gardner MP, Richards M, Ben-Shlomo Y. Cortisol and cognitive function in 
midlife: The role of childhood cognition and educational attainment. 
Psychoneuroendocrinol 2014; 47:189-198. 
28. Beluche I, Carriere I, Ritchie K, Ancelin M. A prospective study of diurnal cortisol and 
cognitive function in community-dwelling elderly people. Psychol Med 2010; 40(6):1039-
1049. 
29. Singh-Manoux A, Dugravot A, Elbaz A, Shipley M, Kivimaki M, Kumari M. No evidence 
of a longitudinal association between diurnal cortisol patterns and cognition. Neurobiol 
Aging 2014; 35:2239-2245. 
30. Thornton PL, Ingram RL, Sonntag WE. Chronic [D-Ala2]-growth hormone-releasing 
hormone administration attenuates age-related deficits in spatial memory. J Gerontol A 
Biol Sci Med Sci 2000; 55(2):B106-B112. 
31. Sonntag WE, Ramsey M, Carter CS. Growth hormone and insulin-like growth factor-1 
(IGF-1) and their influence on cognitive aging. Aging Res Rev 2005; 4(2):195-212. 
32. Bellar D, Glickman EL, Juvancic-Heltzel J, Gunstad J. Serum insulin like growth factor-1 
is associated with working memory, executive function and selective attention in a sample 
of health, fit older adults. Neuroscience 2011; 178:133-137. 
33. Aleman A, Torres-Aleman I. Circulating insulin-like growth factor 1 and cognitive 
function: neuromodulation throughout the lifespan. Prog Neurobiol 2009; 89(3):256-265. 
 
17 
34. Saunders NL, Summers MJ. Attention and working memory deficits in mild cognitive 
impairment. J Clin Exp Neuropsychol 2010; 32(4):350-357. 
35. Stanley TL, Chen CY, Branch KL, Makimura H, Grinspoon SK. Effects of a growth 
hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity 
in healthy men. J Clin Endocrinol Metab 2011; 96(1):150-158. 
36. Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid 
disorders and mood disorders. J Neuroendocrinol 2008; 20:1101-1114. 
37. Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment 
reversibility. Minerva Endocrinol 2007; 32:49-65.  
38. Schrami FV, Goslar PW, Baxter L, Beason-Held LL. Thyroid stimulating hormone and 
cognition during severe, transient hypothyroidism. Neuro Endocrinol Lett 2011; 
32(3):279-285. 
39. Miller KJ, Parsons TD, Whybrow PC, Van Herle K, Rasgon N, Van Herle A, Martinez D, 
Silverman DH, Bauer M. Verbal memory retrieval deficits associated with untreated 
hypothyroidism. J Neuropsychiatry Clin Neurosci 2007; 19(2):132-136. 
40. Iregren A, Gamberale F, Kjellberg A. SPES: A psychological test system to diagnose 
environmental hazards. Neurotoxicol Terotol 1996; 18(4):485-491. 
41. 2008 Physical activity guidelines for Americans. Washington (DC). US Department of 
Health and Human Services, 2008 http://www.health.gov/paguidelines/pdf/paguide.pdf. 
(Accessed on 20 April 2014). 
42. Goh VHH, Hart WG. Associations of physical exercise as a lifestyle habit with lean and 
fat body mass and handgrip strength and age in Asian men. The Aging Male 2014; 
17(3):131-5 
43. Sufi S, Donalson A, Jeffcoate SL. Method Manual. WHO Special Programme of Research, 
Development and Research Training in Human Reproduction. Programme for the 
provision of matched assay reagents for the radioimmunoassay of hormones in 
reproductive physiology. Geneva: World Health Organization. 1992. 
44. Goh HH, Chow A, Wang FL, Ratnam SS. Comparisons of a tritium labelled-based 
classical radioimmunoassay with a newly developed scintillation proximity assay for 
measurement of plasma oestradiol-17-beta. J Med Lab Sci 1990; 4:33-35. 
45. Chia SE, Goh VHH, Ong CN. Endocrine profiles of male workers with exposure to 
trichloroethylene. Am J Ind Med 1997; 32:217-222. 
46. Nicole M. Probst-Hensch, Hao Wang, Victor H. H. Goh, Adeline Seow, Hin-Peng Lee and 
Mimi C. Yu. Determinants of Circulating Insulin-like Growth Factor I and Insulin-like Growth 
Factor Binding Protein 3 Concentrations in a Cohort of Singapore Men and Women Cancer 
Epidemiology Biomarkers & Prevention Vol. 12, 739-746,  August 2003  
47. Goh VHH, Mu SC, Gao FK & Lim KS. Changes in body composition and endocrine and 
metabolic functions in healthy elderly Chinese men following growth hormone therapy. 
The Aging Male (US), 1998; 1(4): 264-269. 
48. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the 
estimation of free testosterone in serum.  J Clin Endocrinol Metab 1999; 84:3666-3672. 
49. Rowe JW, Kahn RL. Human aging: usual and successful. Science 1987; 237:143-146. 
50. Manton KG, Gu X. Changes in the prevalence of chronic disability in the United States 
black and nonblack population above 65 from 1982 to 1999. Proc Natl Acad Sci 2001; 
98:6354-6359. 
51. Park DC, Lautenschlager G, Hedden T, Davidson NS, Smith AD, Smith PK. Models of 
visuospatial and verbal memory across the adult life span. Psychol Aging 2002; 17:299-
320. 
52. Sliwinski M, Buschke H. Cross-sectional and longitudinal relationships among age, 
cognition, and processing speed. Psychol Aging 1999; 14:18-33. 
 
18 
53. Kimura D. Sex hormones influence human cognitive pattern. Neuroendocrinol Lett 2002; 
23(Suppl 4):67-77. 
54. Hampson E, Rovet JF, Altmann D. Spatial reasoning in children with congenital adrenal 
hyperplasia due to 21-hydroxylase deficiency. Develop Neuropsychol 1998; 14:299-320. 
55. Imperato-McGinley J, Pichardo M, Gautier T, Voyer D, Bryden MP. Cognitive abilities in 
androgen-insensitive subjects: Comparison with control males and females from the same 
kindred. Clin Endocrinol 1991; 34:341-347.  
56. Slabbekoorn D, van Goozen SHM, Megens J, Gooren LJG, Cohen-Kettenis PT. Activating 
effects of cross-sex hormones on cognitive functioning: A study of short-term and long 
term hormone effects in transsexuals. Psychoneuroendocrinol 1999; 24:423-447.  
57. Beauchet O. Testosterone and cognitive function: current clinical evidence of a 
relationship. A Review. Eur J Endocrinol 2006; 155:773-781. 
58. Ulubaev A, Lee DM, Purandare N, Pendleton N, Wu FC. Activational effects of sex 
hormones on cognition in men. Clin Endocrinol 2009; 71(5):607-623. 
59. Holland J, Bandelow S, Hogervorst E. Testosterone levels and cognition in elderly men: a 
review. Maturitas 2011; 69(4):322-337.  
60. Martin DM, Wittert G, Burns NR, Haren MT, Sugarman R. Testosterone and cognitive 
function in ageing men: data from the Florey Adelaide Male Ageing Study (FAMAS). 
Maturitas 2007; 57(2):182-194. 
61. Muller M, Aleman A, Grobbee DE, de Haan EHF, van der Schouw YT. Endogenous sex 
hormone levels and cognitive function in aging men: is there an optimal level? Neurology 
2005; 64(5):866-871. 
62. Van Niekerk JK, Huppert FA, Herbert J. Salivary cortisol and DHEA: association with 
measures of cognition and well-being in normal older men, and effects of three months of 
DHEA supplementation. Psychoneuroendocrinol 2001; 26:591-612. 
63. Karishma KK, Hertber J. Dehydroepiandrosterone stimulates neurogenesis in the 
hippocampus of the rat, promotes survival of newly formed neurons, and prevents 
corticosterone-induced suppression. Eur J Neurosci 2002; 16:445-453. 
64. Orentreich N, Brind JL, Vogelman JH Andres R, Baldwin H. Long-term longitudinal 
measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol 
Metab 1992; 75:1002-1004. 
65. Labrie F. DHEA, important source of sex steroids in men and even more in women. Prog 
Brain Res 2010; 182:97-148.  
66. Goh VHH. Tong TYY. Sleep, sex steroid hormones, sexual activities, and aging in Asian 
men. J Androl 2010; 31(2):131-137. 
67. Rothman SM, Mattson MP. Adverse stress, hippocampal networks, and Alzheimer’s 
disease. Neuromolecular Med 2010; 12:56-70. 
68. Karlamangla AS, Singer BH, Chodosh J, McEwen BS, Seeman TE. Urinary cortisol 
excretion as a predictor of incident cognitive impairment. Neurobiol Aging 2005; 
26(Suppl 1):80-84. 
69. Comijs HC, Gerritsen L, Penninx BW, Bremmer MA, Deeg DJ, Geerlings MI. The 
association between serum cortisol and cognitive decline in older person. Am J Geriatr 
Psychiat 2010; 18:42-50. 
70. Ben-Shlomo Y, Gardner M, Lightman S. A life course approach to neuroendocrine 
systems: the example of the HPA axis. In: Kuh D, Cooper R, Hardy R, Richards M, Ben-
Shlomo Y (eds), A life Course Approach to Healthy Ageing. 2014, pp 133-145. Oxford, 
UK: Oxford University Press.  
71. Deijen JB, Arwert LI, Drent ML. The GH/IGF-1 Axis and cognitive changes across a 4-
year period in healthy adults. ISRN Endocrinol 2011; 2011:249421. DOI: 
10.5402/2011/249421.Epub Apr 3 2011. 
 
19 
72. Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD Craft S, Vitiello MV. 
Effects of growth hormone-releasing hormone on cognitive function in adults with mild 


















































Table 1: Linear regression analyses of age with endocrine factors and cognitive functions using 
the stepwise method of analyses. 
 
Age vs Beta  p-value 
DHEAS -0.198 <0.001 
SHBG 0.225 <0.001 
T4 -0.159 <0.001 
Glu 0.094 0.029 
METmin 0.158 <0.001 
T -0.164 <0.001 
BioT -0.170 <0.001 
E2 0.121 0.006 
IGF1 -0.095 0.028 
RT 0.179 <0.001 
Err -0.081 NS 
DSpan -0.027 NS 
BP3 -0.018 NS 
IgfBpR 0.009 NS 
INS -0.007 NS 
Cor 0.046 NS 
TSH -0.061 NS 





























Table 2: Linear regression analyses separately of Err, RT and DSpan with various endocrine 
factors using the stepwise method of analysis. 
 
Err Beta  p-value RT Beta  p-value DSpan Beta p-value 
GLU 0.173 <0.001 Age 0.241 <0.001 GLU -0.111 0.021 
Cor 0.095 0.049 METmin -0.139 0.003 BP3 0.110 0.022 
Age -0.024 NS GLU 0.100 0.032 Age -0.050 NS 
METmin -0.085 NS DHEAS -0.121 0.014 METmin 0.039 NS 
T -0.010 NS T -0.006 NS T 0.052 NS 
SHBG -0.015 NS SHBG 0.025 NS SHBG 0.046 NS 
BioT 0.001 NS BioT -0.017 NS BioT 0.044 NS 
IGF1 0.052 NS IGF1 -0.030 NS IGF1 0.036 NS 
BP3 -0.049 NS BP3 -0.040 NS IGF/BP 0.028 NS 
IGF/BP 0.093 NS IGF/BP -0.001 NS INS 0.008 NS 
INS -0.003 NS INS -0.030 NS Cor 0.004 NS 
E2 0.025 NS Cor 0.025 NS E2 -0.021 NS 
DHEAS 0.004 NS E2 0.055 NS DHEAS 0.006 NS 
TSH -0.024 NS TSH 0.019 NS TSH -0.035 NS 
T4 -0.027 NS T4 0.021 NS T4 -0.037 NS 
T3 -0.012 NS T3 0.001 NS T3 0.008 NS 
 
 
 
 
 
 
 
 
 
 
